Synaptogenix, Inc.
SNPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $4 | $0 | $5 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $3 |
| Gross Profit | $0 | $4 | -$1 | $3 |
| % Margin | – | 100% | – | 50% |
| R&D Expenses | $54 | $149 | $61 | $425 |
| G&A Expenses | $1,948 | $2,191 | $1,008 | $1,754 |
| SG&A Expenses | $1,948 | $2,191 | $1,008 | $1,754 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $700 | $0 | -$1 |
| Operating Expenses | $2,003 | $3,040 | $1,069 | $2,177 |
| Operating Income | -$1,800 | -$3,036 | -$1,069 | -$2,179 |
| % Margin | – | -76,623.8% | – | -40,106.8% |
| Other Income/Exp. Net | -$2,124 | -$14,480 | $1,454 | -$3,368 |
| Pre-Tax Income | -$3,923 | -$17,516 | $385 | -$5,547 |
| Tax Expense | $45 | $0 | $0 | $0 |
| Net Income | -$3,968 | -$17,516 | $385 | -$5,547 |
| % Margin | – | -442,101.9% | – | -102,108.4% |
| EPS | -1.56 | -11.26 | 0.12 | -4.58 |
| % Growth | 86.1% | -9,483.3% | 102.6% | – |
| EPS Diluted | -1.56 | -11.26 | 0.12 | -4.58 |
| Weighted Avg Shares Out | 2,550 | 1,565 | 1,386 | 1,234 |
| Weighted Avg Shares Out Dil | 2,550 | 1,565 | 1,393 | 1,234 |
| Supplemental Information | – | – | – | – |
| Interest Income | $43 | $153 | $182 | $181 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$3,922 | -$2,335 | $386 | -$2,177 |
| % Margin | – | -58,935.1% | – | -40,085.2% |